Jenni Björnulfson
Chief Executive Officer chez LIDDS AB
Profil
Jenni Björnulfson is currently the Director at The C Story AB, Manager-Business Area at GHP Specialty Care AB, Chief Executive & Financial Officer at LIDDS AB, and Chief Financial Officer at Cinclus Pharma Holding AB.
Previously, she worked as an Independent Director at Bio Vitos Pharma AB and as the Chief Financial Officer & Manager-IR at Promore Pharma AB.
Ms. Björnulfson has an undergraduate degree from Karolinska Institutet and a graduate degree from Stockholm School of Economics.
Postes actifs de Jenni Björnulfson
| Sociétés | Poste | Début |
|---|---|---|
| GHP SPECIALTY CARE AB (PUBL) | Corporate Officer/Principal | - |
| LIDDS AB | Chief Executive Officer | 01/12/2023 |
| The C Story AB | Director/Board Member | - |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Director of Finance/CFO | - |
Anciens postes connus de Jenni Björnulfson
| Sociétés | Poste | Fin |
|---|---|---|
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Director of Finance/CFO | 25/08/2020 |
| BIO VITOS PHARMA AB | Director/Board Member | - |
Formation de Jenni Björnulfson
| Karolinska Institutet | Undergraduate Degree |
| Stockholm School of Economics | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LIDDS AB | Health Technology |
| BIO VITOS PHARMA AB | Health Technology |
| Entreprise privées | 4 |
|---|---|
GHP Specialty Care AB
 GHP Specialty Care AB Medical/Nursing ServicesHealth Services GHP Specialty Care AB engages in the provision of healthcare services. It operates business through the Nordic Region and Rest of the World segments. The Nordic Region segment conducts business within specialist care, such as spine surgery/spine care, orthopaedics, obesity surgery and diabetes care, gastroenterology, urology, gynaecology, general surgery, arrhythmia, maternal health care, plastic surgery, and specialist dentistry. The Rest of the World segment manages business in the field of diabetes care at one clinic in the United Arab Emirates. The company was founded by Per Båtelson and Johan Wachtmeister in 2006 and is headquartered in Göteborg, Sweden. | Health Services |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Health Technology |
| The C Story AB |
